- ACRONYMS AND DEFINITIONS
- SU - Sulfonylurea
Glimepiride (Amaryl®)
Dosage forms
Tablet
- 1 mg
- 2 mg
- 4 mg
Dosing
Type 2 diabetes
- Starting: 1 - 2 mg once daily
- Maintenance: 2 - 8 mg once daily
- Max: 8 mg once daily
- Increase dose in increments of 1 - 2 mg a day at intervals of 1 - 2 weeks
- For patients at increased risk of hypoglycemia (e.g. kidney disease, elderly), starting dose should be 1 mg
- Tablets are scored and may be cut in two
- Take with first main meal of the day
Kidney disease
- CrCl < 90 ml/min: exposure is increased. Use a starting dose of 1 mg once daily and titrate slowly.
Liver disease
- Has not been studied. Use caution.
Generic / Price
- YES/$Glipizide (Glucotrol®)
Dosage forms
Tablet
- 5 mg
- 10 mg
Dosing
Type 2 diabetes
- Starting: 5 mg once daily
- Maintenance: 10 - 20 mg/day
- Max: 40 mg/day
- Increase dose in increments of 2.5 - 5 mg a day every several days
- Doses above 15 mg a day should be given in 2 divided doses
- For patients at increased risk of hypoglycemia (e.g. kidney disease, elderly), starting dose should be 2.5 mg
- Tablets are scored and may be cut in two
- Take 30 minutes before a meal
Kidney disease
- Exposure is increased. Consider a starting dose of 2.5 mg and titrate slowly.
Liver disease
- Exposure may be increased. Consider a starting dose of 2.5 mg and titrate slowly.
Generic / Price
- YES/$Glipizide (Glucotrol XL®)
Dosage forms
Tablet, extended-release
- 2.5 mg
- 5 mg
- 10 mg
Dosing
Type 2 diabetes
- Starting: 5 mg once daily
- Maintenance: 5 - 10 mg once daily
- Max: 20 mg/day
- Increase dose at intervals of ≥ 7 days
- For patients at increased risk of hypoglycemia (e.g. kidney disease, elderly), a starting dose of 2.5 mg may be appropriate
- Do not cut, chew, or divide tablets
- Take with first major meal of the day
Kidney disease
- Exposure is increased. Consider a starting dose of 2.5 mg and titrate slowly.
Liver disease
- Exposure may be increased. Consider a starting dose of 2.5 mg and titrate slowly.
Generic / Price
- YES/$Glyburide (Micronase®)
Dosage forms
Tablet
- 1.25 mg
- 2.5 mg
- 5 mg
Dosing
Type 2 diabetes
- Starting: 2.5 - 5 mg once daily
- Maintenance: 2.5 - 20 mg/day
- Max: 20 mg/day
- May be given once daily or in 2 divided doses
- Increase dose in increments of 2.5 mg a day at weekly intervals
- Doses > 10 mg a day may have a better response with twice daily dosing
- For patients at increased risk of hypoglycemia (e.g. kidney disease, elderly), a starting dose of 1.25 mg may be appropriate
- Tablets are scored and may be cut in two
- Take with a meal
Kidney disease
- Exposure may be increased. Use a lower starting dose and titrate slowly.
Liver disease
- Exposure may be increased. Use a lower starting dose and titrate slowly.
Generic / Price
- YES/$Glyburide (Diabeta®)
Dosage forms
Tablet
- 1.25 mg
- 2.5 mg
- 5 mg
Dosing
Type 2 diabetes
- Starting: 2.5 - 5 mg once daily
- Maintenance: 2.5 - 20 mg/day
- Max: 20 mg/day
- May be given once daily or in 2 divided doses
- Increase dose in increments of 2.5 mg a day at weekly intervals
- Doses > 10 mg a day may have a better response with twice daily dosing
- For patients at increased risk of hypoglycemia (e.g. kidney disease, elderly), a starting dose of 1.25 mg may be appropriate
- Tablets are scored and may be cut in two
- Take with a meal
Kidney disease
- Exposure may be increased. Use a lower starting dose and titrate slowly.
Liver disease
- Exposure may be increased. Use a lower starting dose and titrate slowly.
Generic / Price
- YES/?Glyburide (Glynase® PresTab®)
Dosage forms
Tablet
- 1.5 mg
- 3 mg
- 6 mg
Dosing
Type 2 diabetes
- Starting: 1.5 - 3 mg once daily
- Maintenance: 1.5 - 12 mg/day
- Max: 12 mg/day
- May be given once daily or in 2 divided doses
- Increase dose in increments of 1.5 mg a day at weekly intervals
- Doses > 6 mg a day may have a better response with twice daily dosing
- For patients at increased risk of hypoglycemia (e.g. kidney disease, elderly), a starting dose of 0.75 mg may be appropriate
- Tablets are scored and may be cut in two
- Take with a meal
Kidney disease
- Exposure may be increased. Use a lower starting dose and titrate slowly.
Liver disease
- Exposure may be increased. Use a lower starting dose and titrate slowly.
Generic / Price
- YES/$Glucovance® (glyburide + metformin)
Dosage forms
Tablet
- Glyburide - Metformin
- 1.25 mg - 250 mg
- 2.5 mg - 500 mg
- 5 mg - 500 mg
Dosing
Type 2 diabetes
- Starting: 1.25/250 mg once or twice daily with meals
- Max: glyburide 20 mg/day; metformin 2000 mg/day
- Increase dose in increments of 1.25/250 mg/day at intervals of 2 weeks
- Take with meals
Generic / Price
- YES/$Metaglip® (glipizide + metformin)
Dosage forms
Tablet
- Glipizide - Metformin
- 2.5 mg - 250 mg
- 2.5 mg - 500 mg
- 5 mg - 500 mg
Dosing
Type 2 diabetes
- Starting: 2.5/250 - 2.5/500 mg once or twice daily with meals
- Max: glipizide 20 mg/day; metformin 2000 mg/day
- Increase dose in increments of 2.5/250 mg/day at intervals of 2 weeks
- Take with meals
Generic / Price
- YES/$Duetact® (pioglitazone + glimepiride)
Dosage forms
Tablet
- Pioglitazone - Glimepiride
- 30 mg - 2 mg
- 30 mg - 4 mg
Dosing
Type 2 diabetes
- Starting: 30/2 - 30/4 mg once daily
- Max: 30/4 mg once daily
- Titrate to effect
- Take with first main meal
Generic / Price
- YES/$$$- Kidney disease dosing
- Glimepiride (Amaryl)
- CrCl < 90 ml/min: exposure is increased. Use a starting dose of 1 mg once daily and titrate slowly.
- Glipizide (Glucotrol, Glucotrol XL)
- Exposure is increased. Consider a starting dose of 2.5 mg and titrate slowly.
- Glyburide (Micronase, DiaBeta, Glynase)
- Exposure may be increased. Use a lower starting dose and titrate slowly.
- Liver disease
- Glimepiride (Amaryl)
- Has not been studied. Use caution.
- Glipizide (Glucotrol, Glucotrol XL)
- Exposure may be increased. Consider a starting dose of 2.5 mg and titrate slowly.
- Glyburide (Micronase, Diabeta, Glynase)
- Exposure may be increased. Use a lower starting dose and titrate slowly.
- DRUG INTERACTIONS
- NOTE: The drug interactions presented here are NOT all-inclusive. Other interactions may exist. Drug interaction checkers provide the most efficient and practical way to check for interactions among multiple medications. A free interaction checker is available from Drugs.com (see Drugs.com interactions checker).
- All sulfonylureas
- Aspirin - Aspirin may potentiate the effects of sulfonylureas. The significance of this effect with low-dose aspirin is unclear.
- Beta blockers (ex. propranolol, metoprolol, etc.) - Beta blockers may potentiate the effect of sulfonylureas. The significance of this effect is unclear.
- Clarithromycin (Biaxin®) - Clarithromycin may potentiate the effect of sulfonylureas. The significance of this effect is unclear.
- Colesevelam (Welchol™) - colesevelam decreases the absorption of sulfonylureas. Take sulfonylureas at least 4 hours prior to colesevelam.
- CYP2C9 inhibitors and inducers - may affect blood levels of sulfonylureas
- NSAIDs (ibuprofen, naprosyn, Motrin®, etc.) - NSAIDs may potentiate the effect of sulfonylureas. The significance of this effect is unclear.
- Quinolone antibiotics (Levaquin®, Cipro®, gatifloxacin, etc.) - Quinolone antibiotics may potentiate the effects of glyburide and glipizide. Monitor for hypoglycemia.
- Sulfamethoxazole (Bactrim®) - Sulfamethoxazole may potentiate the effect of sulfonylureas. The significance of this effect is unclear.
- Topiramate (Topamax®) - Topiramate may decrease glyburide levels
- Warfarin (Coumadin®) - In an observational study, the combined use of warfarin with glimepiride or glipizide was associated with a higher risk of hypoglycemia in patients ≥ 65 years old. The mechanism behind this possible interaction is unclear.
- Glyburide (Diabeta®)
- Bosentan (Tracleer®) - glyburide should not be given with bosentan. Liver enzyme elevations have occurred.
- Metabolism and clearance
- PRICE ($) INFO
Pricing legend
- $ = 0 - $50
- $$ = $51 - $100
- $$$ = $101 - $150
- $$$$ = > $150
- Pricing based on one month of therapy at standard dosing in an adult
- Pricing based on information from GoodRX.com®
- Pricing may vary by region and availability
- BIBLIOGRAPHY
- Manufacturer's package insert
- 2 - PMID 26643108 - Warfarin and sulfonylurea